Tech Stock News
Sunday, October 2, 2022
The stock of Xeris Pharmaceuticals Inc (NASDAQ: XERS) declined by a margin of 4.57% to eventually settle at $3.87. Xeris moves into a definitive agreement with Strongbridge, eventually taking up the company both in contingent value rights (“CVRs”) and stock. The agreement places a price tag of about $267 million […]
Xeris Pharmaceuticals Inc (NASDAQ: XERS) was up 2.4% in the pre-market today, and its current share price is $3.75. Over the past week, this stock has gained 25.32%. Despite showing the red graphs, XERS is still among the top biotechnology stocks at the moment. According to Investors Observer, this stock […]